Is Intellia Therapeutics (NTLA) Pricing Make Sense After Recent 35% Monthly Surge [Yahoo! Finance]
Intellia Therapeutics, Inc. (NTLA)
Last intellia therapeutics, inc. earnings: 2/27 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.intelliatx.com/investor-overview
Company Research
Source: Yahoo! Finance
If you are wondering whether Intellia Therapeutics is attractively priced or still too expensive at around US$12.50, it helps to break the story into what the market has done recently and what the underlying valuation says. Over the short term, the stock has been lively, with returns of 9.4% over the last 7 days, 35.4% over the last 30 days, and 35.7% year to date, but also a 31.6% return over the past year alongside much weaker 3 year and 5 year returns of 65.2% and 82.5% declines. These moves sit against an evergreen backdrop where Intellia keeps drawing attention for its gene editing pipeline and ongoing program updates that investors watch closely for progress or setbacks. This article steps back from the day to day headlines to focus on what those swings might mean for pricing, rather than trying to interpret each individual announcement. Right now, Intellia scores a 2 out of 6 valuation checks . This suggests the market may only be pricing it favorably on a couple of basi
Show less
Read more
Impact Snapshot
Event Time:
NTLA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTLA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTLA alerts
High impacting Intellia Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
NTLA
News
- Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Intellia Therapeutics: 2 Major Catalysts Will Determine Stock's Trajectory In 2026 [Seeking Alpha]Seeking Alpha
- Baird Updates Intellia Therapeutics, Inc. (NTLA)'s Financial Model Following Nex-Z Clinical Hold Removal [Yahoo! Finance]Yahoo! Finance
- NTLA Stock Up More Than 6% as FDA Lifts ATTRv-PN Study Clinical Hold [Yahoo! Finance]Yahoo! Finance
- Intellia Therapeutics (NASDAQ:NTLA) was given a new $25.00 price target on by analysts at KeyCorp.MarketBeat
NTLA
Earnings
- 11/6/25 - Beat
NTLA
Sec Filings
- 2/3/26 - Form SCHEDULE
- 1/30/26 - Form SCHEDULE
- 1/27/26 - Form 8-K
- NTLA's page on the SEC website